Antibody Discovery Market Fueled By Rising Demand For Precision Therapeutics: Critical Driver Shaping the Antibody Discovery Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Antibody Discovery Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the antibody discovery market has experienced quick expansion. It is forecasted to rise from $8.96 billion in 2024 to $9.87 billion in 2025 with a compound annual growth rate (CAGR) of 10.2%. The historic growth has been driven by an increase in financial support for drug discovery, growing investment in research and development work, and the availability of various health research centers and academic institutions.

Antibody Discovery Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the antibody discovery market is anticipated to experience significant expansion, expected to reach $14.6 billion by 2029, with a CAGR of 10.3%. This growth during the projected period is primarily due to the rising demand for antibody drug discovery services and platforms, increased funding towards the advancement of new technologies, the climbing demand for precision therapeutics, and an expansion in antibody use beyond traditional therapeutic uses. Key trends in this forecast period feature heightened research and development efforts, a growing demand for monoclonal antibodies, increased uptake of advanced technologies, increased demand for targeted therapeutics, and the creation of new antibody formats.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

What Are the Drivers Transforming the Antibody Discovery Market?
The antibody discovery market is set to witness significant growth due to the increasing demand for precision therapeutics. Precision therapeutics, also known as personalized treatment, involves tailoring medical treatments and interventions to the unique characteristics of each patient. Antibody discovery plays a pivotal role in this area, allowing for the creation of targeted therapies like monoclonal antibodies. These therapies are specially designed to interact only with disease-related cells or molecules, providing more effective and custom-fit treatment. For instance, the US-based Personalized Medicine Coalition noted that in January 2023, out of the 35 therapeutic new molecular entities (NMEs) approved in 2022 by the Food and Drug Administration's Center for Drug Evaluation and Research (CDER), around 34% or 12 of them, are considered as personalized medicines. This escalating demand for precision therapeutics is expected to spur the growth of the antibody discovery market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

What Long-Term Trends Will Define the Future of the Antibody Discovery Market?
Leading companies engaged in the antibody discovery industry are pioneering new technologies, including an AI-powered computational antibody drug discovery platform, to enhance the accuracy and speed of antibody development. This type of platform leverages artificial intelligence and computational methodology to fast-track the detection and finetuning of therapeutic antibodies. For example, SwiftPharma BV, a Belgium-based firm that creates recombinant proteins from a unique plant-based system, launched an artificial intelligence-centric antibody discovery platform in October 2023. This new-age solution integrates AI, big data, machine learning, and phage display techniques for swift and precise prediction of high-specificity and high-affinity antibody-antigen connections. This strategy, similar to natural language processing, gives rise to varied antibody sequences, allowing SwiftPharma to generate extensive antibody libraries effectively. This sophisticated system paves the way for the swift discovery of potential antibody drugs with unparalleled quickness.

Which Segments in the Antibody Discovery Market Offer the Most Profit Potential?
The antibody discovery market covered in this report is segmented -

1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Subsegments:
1) By Phage Display: Selection And Screening Techniques, Optimization Methods
2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes
3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

Which Firms Dominate the Antibody Discovery Market by Market Share and Revenue in 2025?
Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

Which Regions Offer the Highest Growth Potential in the Antibody Discovery Market?
North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.